Core EM

OCTOBER 16, 2024

Author: Natalie Bertrand, MD Editor: Naillid Felipe, MD Background: Definition: adverse reaction to blood product administration Incidence: more common in children than adults, except for delayed hemolytic transfusion reactions Allergic (non-anaphylaxis) – Platelets 1-3%; RBCs 0.1-0.3% 2013 Feb;160(4):434-44.

Allergic Reaction 188

Allergic Reaction Plasma ED Epinephrine 188

Core EM

OCTOBER 2, 2024

Author: Natalie Bertrand, MD Editor: Naillid Felipe, MD Background: Definition: adverse reaction to blood product administration Incidence: more common in children than adults, except for delayed hemolytic transfusion reactions Allergic (non-anaphylaxis) – Platelets 1-3%; RBCs 0.1-0.3% 2013 Feb;160(4):434-44.

Allergic Reaction 100

Allergic Reaction Plasma ED Epinephrine 100

REBEL EM

SEPTEMBER 13, 2023

Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergic reaction. Urticaria and pruritus = MAST CELL mediated, which is treated like a standard allergic reaction. J Emerg Med 2013; 44 (4): 764-772. of people who take NSAIDs ( Nzeako 2010 ). 2015; 372(5):418-25. 2013;24:53-66.

Frozen Plasma 101

Frozen Plasma Allergic Reaction FFP Plasma 101

REBEL EM

SEPTEMBER 28, 2023

Primary PCI: 95.7% Stents Placed: Pharmaco-Invasive Treatment: 97.4% Primary PCI: 95.7% ECG Results: Repeat ECG 90min after tenecteplase indicated 70.3% of patients in the pharmaco-invasive treatment achieved ≥50% resolution in the lead with the greatest ST-segment elevation Median decline from 3.0 Primary PCI: 78.4% Primary PCI: 13.3%

STEMI 137

STEMI Allergic Reaction Coronary Ambulance 137

EMDocs

NOVEMBER 13, 2023

An understanding of the risks involved including allergic reaction, radiation exposure, contrast extravasation, and contrast-associated nephropathy allows for a thorough risk-benefit analysis prior to ordering these studies. Am Surg 2013, 79 (1), 23-29. Eur Radiol 2013, 23 (6), 1443-1449. Radiology 2013, 267 (1), 119-128.

E-9-1-1 105

E-9-1-1 ALS Emergency Department ED 105

This Podcast Will Kill You

JANUARY 14, 2025

FDA approves first medication to help reduce allergic reactions to multiple foods after accidental exposure. 2013): 966-973. Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions. .” Allergologie select 6 (2022): 248. Feb 16, 2024. FDA News Release. link] Igea, J. ” Allergy 68.8

Allergic Reaction 52

Allergic Reaction E-9-1-1 Epinephrine ALS 52

This Podcast Will Kill You

JANUARY 7, 2025

Sometimes it seems like the world is out to get us: bees in our garden, pollen in the air, nuts in our brownies, any number of other things that could trigger an allergic reaction ranging from itchy eyes and a runny nose all the way to anaphylaxis. ” Clinical & Experimental Allergy 43.10 (2013): 1110-1123. Josephs, D.

E-9-1-1 52

E-9-1-1 Allergic Reaction PIER ALS 52